Article
Etoposide Quinone Is a Redox-Dependent Topoisomerase II Poison
19 May 2011
Abstract excerpt
Etoposide is a topoisomerase II poison that is used to treat a variety of human cancers. Unfortunately, 2-3% of patients treated with etoposide develop treatment-related leukemias characterized by 11q23 chromosomal rearrangements. The molecular basis for etoposide-induced leukemogenesis is not understood but is associated with enzyme-mediated DNA cleavage. Etoposide is metabolized by CYP3A4 to etoposide catechol,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
